Butyrate may also exert its anti-inflammatory effects directly, by suppressing the expression of pro-inflammatory cytokines in intestinal macrophages via HDAC inhibition, leading to reduced colonic inflammation and colon cancer progression in mice (55, 74). The gene discussed is HDAC9; the disease is malignant colon neoplasm.